Ho Kee Koon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ho Kee Koon has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Yin Ting Cheung
School of Pharmacy, Faculty of Medicine The Chinese University of Hong Kong Hong Kong China
3 shared publications - Chun Sing Lam
Integrative Medicine and Wellness Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA
2 shared publications - Vincent Chi Ho Chung
Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
2 shared publications Chun Sing Lam
Affiliation School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong
1 shared publicationChung Tin Ma
School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, 8th Floor, Lo Kwee-Seong Integrated Biomedical Sciences Building, Area 39, Shatin, NT, Hong Kong
1 shared publication- Herbert Hf Loong
Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China
1 shared publication
Latest Publications
- Open Access
- 24 September 2023
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 58, 152-159
Association between potential supplement–drug interactions and liver diseases in patients with cancer: A large prospective cohort study
- 24 September 2023
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 58, 152-159
Open AccessAssociation between potential supplement–drug interactions and liver diseases in patients with cancer: A large prospective cohort study
- 7 June 2022
- Published by Elsevier in Phytomedicine
- Vol. 103, 154247
Real-world data on herb-drug interactions in oncology: A scoping review of pharmacoepidemiological studies
- 7 June 2022
- Published by Elsevier in Phytomedicine
- Vol. 103, 154247
Real-world data on herb-drug interactions in oncology: A scoping review of pharmacoepidemiological studies
- Open Access
- 1 July 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (7) , e0253890
A public survey of traditional, complementary and integrative medicine use during the COVID-19 outbreak in Hong Kong
Background: During COVID-19, the public actively sought non-pharmacological and self-management approaches to prevent infection. Little is known on the use of traditional, complementary and integrative medicine (TCIM) by the public as preventive measures. This study investigated the prevalence and patterns of TCIM use during the pandemic, and identified factors associated with its use among the general population in Hong Kong. Methods: An online cross-sectional survey was conducted from November to December 2020. The survey solicited information on the respondents’ sociodemographic characteristics, risk perception of the pandemic, and use of TCIM before and during the pandemic. Logistic regression analysis was conducted to determine predictors of TCIM use. Results: In total, 632 responses (completion rate = 88.1%) were analyzed. TCIM was used by 44.0% of respondents during the pandemic. The most popular forms of TCIM were vitamins or other dietary supplements (n = 160, 25.3%) and Chinese herbal medicine (n = 122, 19.3%) during the pandemic. The most frequently reported indication was strengthening the immune system, especially for vitamins or other dietary supplements (n = 142/160, 88.8%). Respondents who reported using TCIM were more likely to be female (adjusted odds ratio [aOR] = 1.82, 95% confidence interval [CI] = 1.29–2.59), had higher education attainment (aOR = 2.21, 95% CI = 1.39–3.59), and older-aged (age >55 years: aOR = 1.77, 95% CI = 1.04–3.02). Respondents who resided in districts with moderate to high number of confirmed COVID-19 cases (aOR = 1.60, 95% CI = 1.07–2.42) and had a higher level of risk perception (aOR = 1.04, 95% CI = 1.01–1.07) were also more likely to use TCIM. Conclusion: TCIM was used commonly in Hong Kong during the COVID-19 pandemic. While vaccination and social distancing remain the mainstay of controlling the pandemic, professional bodies should proactively consider public preferences and provide information regarding the effectiveness and safety of TCIM for COVID-19 prevention and treatment.
- 1 July 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (7) , e0253890
Open AccessA public survey of traditional, complementary and integrative medicine use during the COVID-19 outbreak in Hong Kong
Background: During COVID-19, the public actively sought non-pharmacological and self-management approaches to prevent infection. Little is known on the use of traditional, complementary and integrative medicine (TCIM) by the public as preventive measures. This study investigated the prevalence and patterns of TCIM use during the pandemic, and identified factors associated with its use among the general population in Hong Kong. Methods: An online cross-sectional survey was conducted from November to December 2020. The survey solicited information on the respondents’ sociodemographic characteristics, risk perception of the pandemic, and use of TCIM before and during the pandemic. Logistic regression analysis was conducted to determine predictors of TCIM use. Results: In total, 632 responses (completion rate = 88.1%) were analyzed. TCIM was used by 44.0% of respondents during the pandemic. The most popular forms of TCIM were vitamins or other dietary supplements (n = 160, 25.3%) and Chinese herbal medicine (n = 122, 19.3%) during the pandemic. The most frequently reported indication was strengthening the immune system, especially for vitamins or other dietary supplements (n = 142/160, 88.8%). Respondents who reported using TCIM were more likely to be female (adjusted odds ratio [aOR] = 1.82, 95% confidence interval [CI] = 1.29–2.59), had higher education attainment (aOR = 2.21, 95% CI = 1.39–3.59), and older-aged (age >55 years: aOR = 1.77, 95% CI = 1.04–3.02). Respondents who resided in districts with moderate to high number of confirmed COVID-19 cases (aOR = 1.60, 95% CI = 1.07–2.42) and had a higher level of risk perception (aOR = 1.04, 95% CI = 1.01–1.07) were also more likely to use TCIM. Conclusion: TCIM was used commonly in Hong Kong during the COVID-19 pandemic. While vaccination and social distancing remain the mainstay of controlling the pandemic, professional bodies should proactively consider public preferences and provide information regarding the effectiveness and safety of TCIM for COVID-19 prevention and treatment.